BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12459624)

  • 1. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
    Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
    Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.
    Ando N; Nakao A; Nomoto S; Takeda S; Kaneko T; Kurokawa T; Nonami T; Takagi H
    Pancreas; 1997 Nov; 15(4):374-8. PubMed ID: 9361091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
    Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
    Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
    Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
    J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.
    Tamagawa E; Ueda M; Takahashi S; Sugano K; Uematsu S; Mukai M; Ogata Y; Kitajima M
    Clin Cancer Res; 1997 Nov; 3(11):2143-9. PubMed ID: 9815608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
    Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
    J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras.
    Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Hatakeyama K
    Histopathology; 1998 Mar; 32(3):199-208. PubMed ID: 9568504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations.
    Banerjee SK; Zoubine MN; Mullick M; Weston AP; Cherian R; Campbell DR
    Pancreas; 2000 Apr; 20(3):248-55. PubMed ID: 10766450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of pancreatic cancer patients based on genetic lymph node staging.
    Yamada T; Nakamori S; Ohzato H; Higaki N; Aoki T; Oshima S; Shiozaki K; Okami J; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Int J Oncol; 2000 Jun; 16(6):1165-71. PubMed ID: 10811991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
    Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
    Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
    Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
    Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.
    Ohigashi H; Ishikawa O; Sasaki Y; Yamada T; Furukawa H; Imaoka S; Kasugai T; Ishiguro S; Ueda K; Miyoshi Y; Nakamura Y
    Arch Surg; 2000 Dec; 135(12):1450-5. PubMed ID: 11115351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases.
    Nomoto S; Nakao A; Ando N; Takeda S; Kasai Y; Inoue S; Kaneko T; Takagi H
    Semin Surg Oncol; 1998; 15(1):40-6. PubMed ID: 9671955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.
    Goggins M; Offerhaus GJ; Hilgers W; Griffin CA; Shekher M; Tang D; Sohn TA; Yeo CJ; Kern SE; Hruban RH
    Am J Pathol; 1998 Jun; 152(6):1501-7. PubMed ID: 9626054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.